Tove Nilsson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tove Nilsson has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Henrik Toft Sørensen
Department of Clinical Epidemiology, Center for Population Medicine, Aarhus University Hospital and Aarhus University, Denmark
1 shared publication - Jonathan Montomoli
Department of Anaesthesia and Intensive Care, Infermi Hospital, Romagna Local Health Authority, Rimini, Italy
1 shared publication - Lars Pedersen
Department of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark
1 shared publication - Lisa L. Strate
Division of Gastroenterology, Department of Medicine, Harborview Medical Center, University of Washington Medical School, Seattle, Washington, USA.
1 shared publication - Rune Erichsen
Department of Clinical Epidemiology and Center for Population Medicine, Aarhus University Hospital and Aarhus University, Aarhus, Denmark
1 shared publication
Latest Publications
- 6 January 2015
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (6) , 1832-1840
Coexisting Liver Disease Is Associated with Increased Mortality After Surgery for Diverticular Disease
Coexistence of liver disease in patients undergoing surgery for diverticular disease (DD) may increase the risk of postoperative complications, but the evidence is limited. To investigate the impact of liver disease on mortality and reoperation rates following surgery for DD. We performed a cohort study based on medical databases of all patients undergoing surgery for DD in Denmark during 1977–2011, categorizing them into three cohorts according to history of liver disease: patients with non-cirrhotic liver disease, those with liver cirrhosis, and those without liver disease (comparison cohort). Using the Kaplan–Meier method, we computed mortality in each cohort for 0–30, 31–60, and 61–90 days following surgery for DD. We used a Cox regression model to compute hazard ratios as measures of the relative risk (RR) of death, controlling for potential confounders, including other comorbidities. In addition, we assessed the reoperation rate within 30 days of initial surgery. Of 14,408 patients undergoing surgery for DD, 233 (1.6 %) had non-cirrhotic liver disease and 91 (0.6 %) had liver cirrhosis. Thirty-day mortality was 9.9 % in patients without liver disease and 14.6 % in patients with non-cirrhotic liver disease [adjusted RR = 1.64 (95 % confidence interval [CI] 1.16–2.31)]. Among patients with liver cirrhosis, mortality was 24.2 % [adjusted RR = 2.70 (95 % CI 1.73–4.22)]. Liver cirrhosis had an impact on mortality up to 60 days after surgery for DD. The reoperation rate was approximately 10 % in each cohort. Preexisting liver disease has a major impact on postoperative mortality following surgery for DD.
- 6 January 2015
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (6) , 1832-1840
Coexisting Liver Disease Is Associated with Increased Mortality After Surgery for Diverticular Disease
Coexistence of liver disease in patients undergoing surgery for diverticular disease (DD) may increase the risk of postoperative complications, but the evidence is limited. To investigate the impact of liver disease on mortality and reoperation rates following surgery for DD. We performed a cohort study based on medical databases of all patients undergoing surgery for DD in Denmark during 1977–2011, categorizing them into three cohorts according to history of liver disease: patients with non-cirrhotic liver disease, those with liver cirrhosis, and those without liver disease (comparison cohort). Using the Kaplan–Meier method, we computed mortality in each cohort for 0–30, 31–60, and 61–90 days following surgery for DD. We used a Cox regression model to compute hazard ratios as measures of the relative risk (RR) of death, controlling for potential confounders, including other comorbidities. In addition, we assessed the reoperation rate within 30 days of initial surgery. Of 14,408 patients undergoing surgery for DD, 233 (1.6 %) had non-cirrhotic liver disease and 91 (0.6 %) had liver cirrhosis. Thirty-day mortality was 9.9 % in patients without liver disease and 14.6 % in patients with non-cirrhotic liver disease [adjusted RR = 1.64 (95 % confidence interval [CI] 1.16–2.31)]. Among patients with liver cirrhosis, mortality was 24.2 % [adjusted RR = 2.70 (95 % CI 1.73–4.22)]. Liver cirrhosis had an impact on mortality up to 60 days after surgery for DD. The reoperation rate was approximately 10 % in each cohort. Preexisting liver disease has a major impact on postoperative mortality following surgery for DD.